Ariel Teitel, MD
Rheumatology · New York, NYNPI 1871578450
Payments from drug & device makers
Across 701 payments — averaging $64.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$24K
- AbbVie$7K
- Bristol Myers Squibb$3K
- Sobi, Inc$2K
- AstraZeneca$1K
- UCB, Inc.$1K
- plus $7K from 31 others
What the payments were for
- Consulting fees$2,6796%
- Speaking & faculty fees$21,19847%
- Travel & lodging$1,1783%
- Food & beverage$19,86544%
- Education$1200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 198 | $24,230 |
| AbbVie | 115 | $6,879 |
| Bristol Myers Squibb | 15 | $3,095 |
| Sobi, Inc | 3 | $1,813 |
| AstraZeneca(2 entities) | 43 | $1,099 |
| UCB, Inc. | 50 | $1,078 |
| Novartis | 49 | $1,073 |
| GSK | 45 | $907 |
| Lilly USA, LLC | 44 | $866 |
| Johnson & Johnson(2 entities) | 31 | $709 |
| Mallinckrodt Hospital Products Inc. | 19 | $482 |
| Regeneron Healthcare Solutions, Inc. | 14 | $441 |
| Janssen Scientific Affairs, LLC | 3 | $386 |
| E.r. Squibb & Sons, L.L.C. | 11 | $243 |
| Dr.reddy's Laboratories,inc. | 1 | $238 |
| BD | 1 | $208 |
| Sanofi | 6 | $143 |
| Pfizer | 7 | $135 |
| Genentech USA, Inc. | 6 | $110 |
| Radius Health, Inc. | 4 | $103 |
| Mallinckrodt Enterprises LLC | 4 | $95 |
| IBSA Pharma Inc. | 4 | $87 |
| Boehringer Ingelheim | 3 | $80 |
| Antares Pharma, Inc. | 4 | $74 |
| Aurinia Pharma U.S., Inc. | 2 | $60 |
| Fresenius Kabi USA, LLC | 3 | $58 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $57 |
| CSL Behring | 2 | $43 |
| ANI Pharmaceuticals, Inc. | 2 | $39 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $37 |
| Actelion Pharmaceuticals US, Inc. | 1 | $35 |
| Kowa Pharmaceuticals America, Inc. | 1 | $33 |
| Invivyd Inc | 1 | $28 |
| Scilex Pharmaceuticals Inc. | 1 | $22 |
| Sandoz | 1 | $20 |
| Biogen | 1 | $17 |
| Mylan Institutional Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$45,040 in reported general payments places this provider in the 80th percentile of 541 rheumatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 51 | $362,442 |
| Orencia ClickjectAbatacept | 14 | $92,559 |
| Diclofenac Sodium | 112 | $14,127 |
| Diclofenac Epolamine | 21 | $12,819 |
| Lidocaine | 39 | $5,215 |
| MethotrexateMethotrexate Sodium | 107 | $1,503 |
| Hydroxychloroquine Sulfate | 74 | $1,122 |
| Prednisone | 145 | $943 |
| Duloxetine Hcl | 11 | $880 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $774 |
| Allopurinol | 36 | $483 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $457 |
| Alendronate Sodium | 20 | $383 |
| Sulfasalazine DrSulfasalazine | 15 | $366 |
| Gabapentin | 24 | $337 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in New York
- Amit SaxenaNew York$6.7M
- Robert SpieraNew York$4.3M
- Laurie GlimcherNew York$3.9M
- Anca AskanaseNew York$3.5M
- Grace WrightNew York$3M
- Jose ScherNew York$2.7M
- Sergio SchwartzmanNew York$2.5M
- Allan GibofskyNew York$1.9M
- Laura Geraldino PardillaNew York$1.7M
- Joan BathonNew York$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.